GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
7N8I | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
7ND3 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | |
7ND4 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND5 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND6 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND7 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND8 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7ND9 | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDA | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDB | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDC | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NDD | P0DTC2 | EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 | COVOX-158 heavy chain, COVOX-158 light chain, Spike glycoprotein |
7NEH | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab | |
7NKT | P0DTC2 | RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226 | |
7NT9 | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation) | Spike glycoprotein |
7NTA | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect) | Spike glycoprotein |
7NTC | P0DTC2 | Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab | Spike glycoprotein, P008_056 Fab Heavy chain, P008_056 Fab Light chain |
7NX6 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX7 | P0DTC2 | Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX8 | P0DTC2 | Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NX9 | P0DTC2 | Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXA | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXB | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs | |
7NXC | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2 | |
7OAN | P0DTC2 | Nanobody C5 bound to Spike | |
7OAO | P0DTC2 | Nanobody C5 bound to RBD | |
7OAP | P0DTC2 | Nanobody H3 AND C1 bound to RBD | |
7OAQ | P0DTC2 | Nanobody H3 AND C1 bound to RBD with Kent mutation | |
7OAU | P0DTC2 | Nanobody C5 bound to Kent variant RBD (N501Y) | |
7OAY | P0DTC2 | Nanobody F2 bound to RBD | |
7OR9 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs | |
7ORA | P0DTC2 | Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs | |
7ORB | P0DTC2 | Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs | |
7P77 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation | |
7P78 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation | |
7P79 | P0DTC2 | SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. | |
7P7A | P0DTC2 | SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation | |
7R6W | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
7R6X | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
7R7N | P0DTC2 | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) | |
7R8L | P0DTC2 | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 | |
7R8M | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 | |
7R8N | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 | |
7R8O | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 | |
7RA8 | P0DTC2 | SARS-CoV-2 S glycoprotein in complex with S2X259 Fab | |
7RAL | P0DTC2 | SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) | |
7RW2 | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7D6I | P0DTC2 | A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 | |
7EKH | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024